Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by George Gao and Guizhen Wu.
George Gao
Connection Strength
0.394
Guizhen Wu
  1. Structural basis of HCoV-19 fusion core and an effective inhibition peptide against virus entry. Emerg Microbes Infect. 2020 Dec; 9(1):1238-1241.
    View in: PubMed
    Score: 0.057
  2. Excretion of SARS-CoV-2 through faecal specimens. Emerg Microbes Infect. 2020 Dec; 9(1):2501-2508.
    View in: PubMed
    Score: 0.057
  3. Immune suppression in the early stage of COVID-19 disease. Nat Commun. 2020 11 17; 11(1):5859.
    View in: PubMed
    Score: 0.057
  4. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial. Lancet Infect Dis. 2021 01; 21(1):39-51.
    View in: PubMed
    Score: 0.057
  5. Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2. Cell. 2020 08 06; 182(3):713-721.e9.
    View in: PubMed
    Score: 0.055
  6. A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2. Nature. 2020 08; 584(7819):120-124.
    View in: PubMed
    Score: 0.055
  7. A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2. Science. 2020 06 12; 368(6496):1274-1278.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.